3

OWNERSHIP DOCUMENT

Company: Protagenic Therapeutics, Inc.\new
Filed: September 20, 2011
Period of Report: September 14, 2011
Accession Number: 0001144204-11-054019

View Document ↗ View on SEC.gov ↗